retatrutide and cancer Pharmacological Dissection Identifies Overcomes the Therapeutic Barrier of Obese TNBC Treatments through Suppressing the Interplay between Glycosylation Ubiquitylation of YAP - Cui - 2025 - Advanced Science Eli Lilly's retatrutide drug, not

10.1002/cne.902710405 [DOI] [PubMed] [Google Scholar] Kahles, F

Emerging research suggests allulose may stimulate modest increases in GLP-1 hormone release through the intestinal L-cells, but the magnitude of this effect remains far smaller than therapeutic GLP-1 medications

doi: 10.1038/npp.2017.150, 113 PhelanS

When nothing has changed, they double the dose, switch compounds, or quit entirely

Retatrutide vs Tirzepatide: Which May Be Better

This triple-agonist approach enables researchers to study the combined effects of appetite regulation, insulin secretion, and energy expenditure in a single molecule, making it uniquely valuable for obesity models, metabolic syndrome research, and studies exploring synergistic receptor interactions beyond what dual agonists can achieve